The expression of activation molecules on peripheral-blood CD4 and CD8 T lymphocytes and the serum concentrations of two products of activated T lymphocytes [interferon-(IFN-) and soluble interleukin-2 receptor (sIL-2R)] were measured in patients with acute severe asthma (ASA) and controls. Significantly higher percentages of CD4 + cells from patients with ASA expressed IL-2R, HLA-DR and VLA-1 as compared to controls (p <0.01). In contrast, CD8 + cells from both asthmatics and controls did not express IL-2R and VLA-1, and their expression of HLA-DR in asthmatics was not increased. Serum concentrations of IFN-and sIL-2R were significantly elevated in patients with ASA as compared to control groups (p <0.01). Concentrations decreased as the patients improved clinically following therapy. Significant correlations were observed between the improvements in airways obstruction and (1) the decreases in the percentages of peripheral-blood IL-2R + T lymphocytes and (2) the decreases in serum concentrations of sIL-2R. These observations suggest that CD4 T lymphocyte activation is important in the pathogenesis of ASA. Activated CD4 T lymphocytes, through secretion of lymphokines, have the propensity to regulate granulocyte function and thereby orchestrate inflammatory reactions. For this reason we investigated whether T lymphocyte activation is indeed a feature of asthma. Activation molecules on peripheral-blood CD4 and CD8 T lymphocytes and the serum concentrations of two products of activated T lymphocytes [interferon-γ (IFN-γ) and soluble interleukin-2 receptor (sIL-2R)] were measured in patients with acute severe asthma (ASA) and controls (normals, mild asthma, chronic obstructive pulmonary disease). Significantly higher percentages of CD4 T lymphocytes from patients with ASA expressed surface IL-2R, class II histocompatibility antigen (HLA-DR) and very late activation antigen-1 (VLA-1) as compared to each control group (p < 0.01 in each case). In contrast, CD8 cells from both ASA patients and controls were devoid of IL-2R and VLA-1, whilst the expression of HLA-DR was not increased. Serum concentrations of IFN-γ and sIL-2R were significantly elevated in ASA patients on admission to hospital as compared to controls (p < 0.01 in each case). Concentrations decreased as the patients improved clinically following therapy. Significant (p < O.Ol) correlations were observed between the improvements in peak expiratory flow rate and the decreases in (1) the percentages of IL-2R-positive T lymphocytes and (2) the serum concentrations of sIL-2R. Atopic ASA patients had significantly (p < 0.01) lower percentages of activated CD4 T lymphocytes and serum concentrations of their products on admission than nonatopics. One possible interpretation of this observation is that additional mechanisms (such as those dependent on release of mediators from mast cells) may be more relevant to the genesis of acute bronchospasm in atopic asthmatics. Since various proteins with neutrophil chemotactic activity (NCA) are present in the serum of patients with ASA, we also attempted to determine whether these might be derived, at least in 
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